State Street Corp Omega Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 94,730 shares of OMGA stock, worth $74,836. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,730

Previous 94,730 -0.0%

Holding current value

$74,836

Previous $196,000 41.33%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.86 - $3.2 $719,535 - $1.24 Million	-386,847 Reduced 80.33%	94,730 $196,000
Q1 2024 May 15, 2024	BUY	$2.73 - $5.32 $82,293 - $160,366	30,144 Added 6.68%	481,577 $1.76 Million
Q4 2023 Feb 14, 2024	BUY	$1.35 - $3.21 $22,005 - $52,323	16,300 Added 3.75%	451,433 $1.36 Million
Q3 2023 Nov 14, 2023	BUY	$2.15 - $5.68 $98,900 - $261,280	46,000 Added 11.82%	435,133 $935,000
Q2 2023 Aug 14, 2023	BUY	$5.6 - $9.66 $1.87 Million - $3.22 Million	333,403 Added 598.25%	389,133 $2.18 Million
Q1 2023 May 15, 2023	BUY	$4.81 - $10.95 $20,202 - $45,990	4,200 Added 8.15%	55,730 $336,000
Q4 2022 Feb 14, 2023	BUY	$4.22 - $7.05 $49,796 - $83,190	11,800 Added 29.7%	51,530 $294,000
Q3 2022 Nov 15, 2022	BUY	$3.63 - $6.65 $29,403 - $53,865	8,100 Added 25.61%	39,730 $215,000
Q2 2022 Aug 15, 2022	SELL	$2.01 - $7.19 $368,107 - $1.32 Million	-183,138 Reduced 85.27%	31,630 $120,000
Q1 2022 May 16, 2022	BUY	$6.24 - $14.04 $685,776 - $1.54 Million	109,900 Added 104.8%	214,768 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$11.33 - $29.38 $402,679 - $1.04 Million	35,541 Added 51.27%	104,868 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $22.51 $1.11 Million - $1.56 Million	69,327 New	69,327 $1.31 Million

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $37.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Omega Therapeutics, Inc. Transaction History